BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29500651)

  • 1. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging.
    Lyu HL; Cao JX; Wang HY; Wang ZB; Hu MG; Ma L; Wang YW; Ye HY
    Abdom Radiol (NY); 2018 Oct; 43(10):2712-2720. PubMed ID: 29500651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-echo gradient chemical shift MR imaging fails to differentiate minimal fat renal angiomyolipomas from other homogeneous solid renal tumors.
    Ferré R; Cornelis F; Verkarre V; Eiss D; Correas JM; Grenier N; Hélénon O
    Eur J Radiol; 2015 Mar; 84(3):360-365. PubMed ID: 25547327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.
    Kim JK; Kim SH; Jang YJ; Ahn H; Kim CS; Park H; Lee JW; Kim S; Cho KS
    Radiology; 2006 Apr; 239(1):174-80. PubMed ID: 16507752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
    Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
    Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
    Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
    Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
    Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
    Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
    van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
    Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple pancreatic metastases from clear cell renal carcinoma: diagnosis with chemical shift magnetic resonance imaging before surgery.
    Koyama H; Maruta T; Kudo T; Mayahara H; Yoshida K
    Australas Radiol; 2005 Dec; 49(6):493-6. PubMed ID: 16351615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of rebound and lymphoid thymic hyperplasia from anterior mediastinal tumors with dual-echo chemical-shift MR imaging in adulthood: reliability of the chemical-shift ratio and signal intensity index.
    Priola AM; Priola SM; Ciccone G; Evangelista A; Cataldi A; Gned D; Pazè F; Ducco L; Moretti F; Brundu M; Veltri A
    Radiology; 2015 Jan; 274(1):238-49. PubMed ID: 25105246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
    Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
    Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
    Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
    J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative diagnostic performance of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for differentiating clear cell and non-clear cell renal cell carcinoma.
    Zhao P; Zhu J; Wang L; Li N; Zhang X; Li J; Luo Y; Li Q
    Eur Radiol; 2023 May; 33(5):3766-3774. PubMed ID: 36725722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
    Kang TW; Kim SH; Lee J; Kim AY; Jang KM; Choi D; Kim MJ
    Eur J Radiol; 2015 Nov; 84(11):2089-96. PubMed ID: 26318820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging.
    Jomoto W; Takaki H; Yamamoto S; Kanematsu A; Igeta M; Hirota S; Yamakado K
    In Vivo; 2022; 36(6):2790-2799. PubMed ID: 36309367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.